October 2018


Stock I'm watching this month:-

MYX
- Mayne Pharma Group Limited

Sector: Healthcare
Market Cap: 1.84 Billion
Price/Earnings: N/A
Price/Book: 1.49
Return On Equity: -10.54%
Return On Assets: 2.14%
Debt/Equity: 30.3%

Reasons to watch: MYX is a pharmaceutical company, which manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The valuation looks poor; however is currently trading around Morningstar's Fair Value Estimate, and shows good price momentum.

Sentiment: Buy
Disclosure: Held
My Strike Price: Market Price (Morningstar Fair Value: $1.22)



Disclaimer: This does not constitute any financial advice or stock recommendations. As always, Do Your Own Research.




Comments

Popular posts from this blog

On... Delaying Retirement

On.. Not all DCA are Created Equal

On... 2024